Here are the latest quarterly results of PROCTER & GAMBLE HEALTH. For more details, see the PROCTER & GAMBLE HEALTH financial fact sheet and PROCTER & GAMBLE HEALTH share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,678 | 2,959 | 2,976 | 3,100 | 3,209 | 3,012 | 3,049 | 3,100 | |
Other income | Rs m | 24 | 31 | 34 | 45 | 50 | 55 | 61 | 52 | |
Turnover | Rs m | 2,702 | 2,990 | 3,010 | 3,145 | 3,259 | 3,066 | 3,110 | 3,152 | |
Expenses | Rs m | 1,991 | 2,369 | 2,067 | 2,011 | 2,413 | 2,558 | 2,163 | 2,083 | |
Gross profit | Rs m | 688 | 590 | 908 | 1,089 | 797 | 453 | 887 | 1,017 | |
Depreciation | Rs m | 61 | 75 | 75 | 82 | 59 | 65 | 65 | 69 | |
Interest | Rs m | 1 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | |
Profit before tax | Rs m | 649 | 547 | 866 | 1,049 | 785 | 441 | 881 | 997 | |
Tax | Rs m | 137 | 135 | 229 | 281 | 193 | 143 | 225 | 277 | |
Profit after tax | Rs m | 512 | 412 | 637 | 768 | 592 | 298 | 656 | 721 | |
Gross profit margin | % | 25.7 | 20.0 | 30.5 | 35.1 | 24.8 | 15.1 | 29.1 | 32.8 | |
Effective tax rate | % | 21.1 | 24.6 | 26.5 | 26.8 | 24.6 | 32.4 | 25.5 | 27.7 | |
Net profit margin | % | 19.1 | 13.9 | 21.4 | 24.8 | 18.4 | 9.9 | 21.5 | 23.3 | |
Diluted EPS | Rs | 30.8 | 24.8 | 38.4 | 46.3 | 35.7 | 18.0 | 39.5 | 43.4 | |
Diluted EPS (TTM) | Rs | 111.6 | 116.0 | 121.0 | 140.3 | 145.1 | 138.2 | 139.4 | 136.5 | |
Subscriber Feature |
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.